(Q53910036)

English

A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

author name string

G Voortman

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

B M Mannaerts

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

J A Huisman

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

73

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

1187-1193

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Differences in serum follicle-stimulating hormone uptake after intramuscular and subcutaneous human menopausal gonadotropin injection

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900542-2

7 January 2021

Identifiers

10.1016/S0015-0282(00)00542-2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10856481

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53910036&oldid=1373222888"